0.29 USD
↘ 0.01 (4.35%)AT CLOSE (11:59 AM EDT)
IGC Pharma, Inc.
IGCAMEX • USD
0.29
↗ 0.01 (2.10%)
POST MARKET (AS OF 08:15 PM EDT)
Post Market
AS OF 08:15 PM EDT
0.29
↗ 0.01 (2.10%)
Market: CLOSED
Open?$0.29
High?$0.30
Low?$0.29
Prev. Close?$0.30
Volume?244.6K
Avg. Volume?1.9M
VWAP?$0.29
Rel. Volume?0.13x
Bid / Ask
Bid?$0.29 × 6.2K
Ask?$0.30 × 400
Spread?$0.01
Midpoint?$0.30
Valuation & Ratios
Market Cap?28.7M
Shares Out?98.8M
Float?73.5M
Float %?74.4%
P/E Ratio?N/A
P/B Ratio?3.54
EPS?-$0.07
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.
Address
10224 FALLS ROAD
POTOMAC, MD 20854
Phone: 301-529-4996
POTOMAC, MD 20854
Phone: 301-529-4996
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?1.32Adequate
Quick Ratio?0.89Weak
Cash Ratio?0.73Adequate
Debt/Equity?0.02Low
ValuationFAIRLY VALUED
Score58/100
P/E?N/A▾
P/B?3.54FAIR▾
P/S?25.90HIGH▾
P/FCF?N/A▾
EV/EBITDA?-3.7CHEAP▾
EV/Sales?25.03HIGH▾
Returns & Efficiency
ROE?-79.7%WEAK▾
ROA?-66.2%WEAK▾
Cash Flow & Enterprise
FCF?$-5626000
Enterprise Value?$27.7M
Fundamentals ratios updated end of day